New insights into the pathophysiology and management of bone disease in multiple myeloma.
Terpos
Evangelos
E
Department of Haematology, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, UK.
Politou
Marianna
M
Rahemtulla
Amin
A
D001847:Bone Diseases / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D001862:Bone Resorption; D002352:Carrier Proteins / Q000378:metabolism; D054407:Chemokine CCL4; D016207:Cytokines / Q000378:metabolism; D004164:Diphosphonates / Q000627:therapeutic use; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D019402:Macrophage Inflammatory Proteins / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000378:metabolism; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D053244:Osteoprotegerin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism; D018124:Receptors, Tumor Necrosis Factor
D002352:Carrier Proteins; D054407:Chemokine CCL4; D016207:Cytokines; D004164:Diphosphonates; D006023:Glycoproteins; D019402:Macrophage Inflammatory Proteins; D008562:Membrane Glycoproteins; D053244:Osteoprotegerin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C505686:TNFRSF11A protein, human; C506030:TNFRSF11B protein, human; C505688:TNFSF11 protein, human